Literature DB >> 14706814

In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model.

Silvina A Bravo1, Carsten Uhd Nielsen, Jan Amstrup, Sven Frokjaer, Birger Brodin.   

Abstract

The aim of the present study was to investigate the influence of culture time on hPEPT1-mediated transport in Caco-2 cell monolayers. Peptide transport activity in Caco-2 cells grown in standard media and in a "rapid" 4-day model was first compared. The rapid 4-day Caco-2 cell model, cultured using a cocktail of growth factors and agonists, displayed lower peptide uptake capacity than Caco-2 cells grown for 4 days in conventional media, and was judged to be unsuitable for peptide transport studies. Peptide transport activity as well as monolayer integrity and tissue morphology were evaluated in the standard >21 days model as a function of the culture time. Peptide transport activity was studied using [14C]-glycylsarcosine ([14C]-Gly-Sar). Monolayer integrity was evaluated by transepithelial electrical resistance (TEER) measurements and [3H]-mannitol permeabilities. Tissue morphology and hPEPT1 expression were studied using confocal laser scanning microscopy (CLSM) and conventional staining/immunostaining. Caco-2 cells grown in conventional media became confluent after 3-4 days. Mannitol permeability decreased from day 5 to 21 and TEER increased steadily until approximately day 21. Apical hPEPT1 uptake activity appeared to be maximal in cells cultured for >21 days, whereas basolateral uptake reached a maximum already after 12 days in culture. In some of the passages studied, a secondary increase in hPEPT1 transport activity was observed in cells grown for >25 days. A large carrier-mediated transepithelial peptide flux component was evident from day 14.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14706814     DOI: 10.1016/s0928-0987(03)00205-7

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Transporter and ion channel gene expression after Caco-2 cell differentiation using 2 different microarray technologies.

Authors:  Christopher P Landowski; Pascale Anderle; Duxin Sun; Wolfgang Sadee; Gordon L Amidon
Journal:  AAPS J       Date:  2004-09-07       Impact factor: 4.009

2.  Primary cell lines: false representation or model system? a comparison of four human colorectal tumors and their coordinately established cell lines.

Authors:  Danielle M Pastor; Lisa S Poritz; Thomas L Olson; Christina L Kline; Leonard R Harris; Walter A Koltun; Vernon M Chinchilli; Rosalyn B Irby
Journal:  Int J Clin Exp Med       Date:  2010-02-22

3.  Thrifty, Rapid Intestinal Monolayers (TRIM) Using Caco-2 Epithelial Cells for Oral Drug Delivery Experiments.

Authors:  Nicholas G Lamson; Rebecca L Ball; Katherine C Fein; Kathryn A Whitehead
Journal:  Pharm Res       Date:  2019-10-28       Impact factor: 4.200

Review 4.  Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges.

Authors:  Charles Awortwe; P S Fasinu; B Rosenkranz
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

5.  In Vitro Membrane Permeation Studies and in Vivo Antinociception of Glycosylated Dmt1-DALDA Analogues.

Authors:  Steven Ballet; Cecilia Betti; Alexandre Novoa; Csaba Tömböly; Carsten Uhd Nielsen; Hans Christian Helms; Anna Lesniak; Patrycja Kleczkowska; Nga N Chung; Andrzej W Lipkowski; Birger Brodin; Dirk Tourwé; Peter W Schiller
Journal:  ACS Med Chem Lett       Date:  2014-04-10       Impact factor: 4.345

6.  Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers.

Authors:  Gabriel Kigen; Geoffrey Edwards
Journal:  BMC Pharmacol Toxicol       Date:  2017-05-04       Impact factor: 2.483

7.  Caco-2 cell acquisition of dietary iron(III) invokes a nanoparticulate endocytic pathway.

Authors:  Dora I A Pereira; Bianca I Mergler; Nuno Faria; Sylvaine F A Bruggraber; Mohamad F Aslam; Lynsey K Poots; Laura Prassmayer; Bo Lönnerdal; Andy P Brown; Jonathan J Powell
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.